These results suggest that the expression of the amino-truncated form of NOV is potentially responsible for enhancing the progression and chemoresistance of bladder cancer by inducing EMT and enhancing the serine phosphorylation of GSK-3β and β-catenin. The gene discussed is GSK3B; the disease is urinary bladder carcinoma.